Answers are grounded in this paper and cite their sources.
Severe Combined Immunodeficiencies (SCID) are a heterogeneous group of monogenetic diseases. We describe the typical clinical presentation of patients with SCID as well as basic principles in diagnosis and therapy by hematopoietic stem cell transplantation. Therapeutic strategies may differ between subtypes and the inherent reduced capacity or inablility to reject a graft have to be considered.
No takes yet. Share an insight, caveat, or question.
Haddad et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: